Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07108712

Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases

The Role of Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
The General Authority for Teaching Hospitals and Institutes · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To assess the sensitivity and accuracy of diffusion magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) metrics, in identifying early-stage changes in brain white matter related to various white matter diseases.

Detailed description

Brain white matter diseases (WMDs) are a group of neurological conditions that involve changes to the brain's white matter, often leading to cognitive, motor, and sensory impairments. Diffusion Magnetic Resonance Imaging (dMRI), has emerged as a powerful non-invasive imaging tool for evaluating microstructural changes in brain white matter. This protocol aims to investigate the role of dMRI in the early identification and characterization of brain white matter diseases, focusing on its potential for detecting abnormalities before the onset of overt clinical symptoms. Diffusion-weighted imaging (DWI), one of the first advanced magnetic resonance imaging (MRI) techniques, has rapidly ascended on the basis of its applicability in strokes and some infectious diseases. Restricted diffusion is significant information in the context of vascular ischemia, helping to delimit the brain-damaged area

Conditions

Interventions

TypeNameDescription
OTHERMagnetic Resonance Imaging (MRI)Magnetic Resonance Imaging (MRI) Scanner: All imaging will be performed using a 1.5 tesla MRI scanner to ensure high resolution and signal-to-noise ratio.

Timeline

Start date
2025-05-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-08-07
Last updated
2025-08-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07108712. Inclusion in this directory is not an endorsement.